AGC Biologics to Manufacture AAVantgardes Dual-Vector Gene Therapies for Inherited Retinal Disorders
Partnership accelerates AGC Biologics' leadership in the AAV market, applying its BravoAAV™…
Ares Management Acquires Minority Stake in Plenitude for 2 Billion
LONDON & MILAN--(BUSINESS WIRE)--Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global…